PMV Pharmaceuticals, Inc. - Director's Dealing 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PMV Pharmaceuticals, Inc. (PMVP)
CIK: 0001699382
Period of Report: 2025-04-21

Reporting Person: Ticktin Robert (N/A)

Security	Shares	Ownership
Common Stock	106318	Direct

Security	Exercise Price	Expiration	Underlying	Ownership
Employee Stock Option (right to buy)	$4.22	2030-06-02	Common Stock (1449)	Direct
Employee Stock Option (right to buy)	$8.53	2030-08-28	Common Stock (102460)	Direct
Employee Stock Option (right to buy)	$1.80	2034-01-18	Common Stock (168820)	Direct
Employee Stock Option (right to buy)	$1.48	2034-08-13	Common Stock (196379)	Direct
Employee Stock Option (right to buy)	$1.32	2035-03-03	Common Stock (265000)	Direct

F1: Includes 79,150 shares represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.

F2: Shares subject to the option are fully vested and immediately exercisable.

F3: Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.

F4: One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.

F5: Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.